The store will not work correctly when cookies are disabled.
(4E)-4-[(5-bromo-2-furyl)methylene]-1-(4-iodophenyl)pyrazolidine-3,5-dione
ID: ALA4063743
Chembl Id: CHEMBL4063743
PubChem CID: 17986424
Max Phase: Preclinical
Molecular Formula: C14H8BrIN2O3
Molecular Weight: 459.04
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NN(c2ccc(I)cc2)C(=O)/C1=C/c1ccc(Br)o1
Standard InChI: InChI=1S/C14H8BrIN2O3/c15-12-6-5-10(21-12)7-11-13(19)17-18(14(11)20)9-3-1-8(16)2-4-9/h1-7H,(H,17,19)/b11-7+
Standard InChI Key: CHXVQLIBHFWVNX-YRNVUSSQSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 459.04 | Molecular Weight (Monoisotopic): 457.8763 | AlogP: 3.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 62.55 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.26 | CX Basic pKa: ┄ | CX LogP: 2.89 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.43 | Np Likeness Score: -1.94 |
References
1. (2011) GLEPP-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders, |